BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BG Medical Technologies Announces New Medical Marijuana Division


3/29/2012 10:59:41 AM

LOS ANGELES, March 29, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH), a leader in medical marijuana professional services, announces the formation of a new digital services marketing division to create best-in-class asset management for cannabis related Internet properties.

The new division is aligned to support company initiatives for monetization of high value and high traffic Internet web sites, brands, and virtual properties. The unit will implement a strong focus on demographic, behavioral, and contextual analysis to best deliver relevant content to patients and information seekers of medical cannabis treatments. This will occur across a breadth of new and existing medical marijuana brands. The division will also lay the groundwork for a cannabis-niche advertising network set for release later this year. BG Medical's consistent focus on patient interests supports industry growth rates as new states continue to ratify medical marijuana legalization. Through internal initiatives and contracts currently under negotiation, the branch is expected to produce $2.1 million in revenue of previously stated $6.5 million 2012 year end goals.

"We've consolidated the most creative technology-centric minds from both public and private cannabis companies under one roof to participate in honing the value proposition of our own brands and new brands we're being asked to manage," said Angel Stanz, CEO. "This represents the underlying glue of our 'seed-to-sale' horizontal that will be revealed throughout 2012 as key acquisitions continue to be completed."

BG Medical Technologies owns and operates BudGenius.com, the first cannabis research laboratory to display online results for medical marijuana potency testing and quality control. BudGenius.com remains the most highly visited medical cannabis laboratory website worldwide.

About BG Medical Technologies

BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis.

http://www.BgMedTech.com

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:
Angel Stanz
Chief Executive Officer
pr(at)bgmedtech(dot)com
(855) 723-3283

SOURCE BG Medical Technologies, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES